doxapram and amoxapine

doxapram has been researched along with amoxapine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Andersson, JA; Chauhan, S; Chopra, AK; Dann, SM; Fitts, EC; Kirtley, ML; Motin, VL; Peniche, AG; Ponnusamy, D; Rosenzweig, JA; Sha, J	1
Andersson, JA; Boonma, P; Chopra, AK; Dann, SM; Galindo, CL; Luna, RA; Peniche, AG; Savidge, TC; Sha, J	1

Reviews

1 review(s) available for doxapram and amoxapine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for doxapram and amoxapine

Article	Year
New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amoxapine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Clostridioides difficile; Disease Models, Animal; Doxapram; Drug Administration Schedule; Drug Repositioning; Enterocolitis, Pseudomembranous; Female; High-Throughput Screening Assays; Macrophages; Mice; Plague; Prescription Drugs; Salmonella Infections; Salmonella typhimurium; Small Molecule Libraries; Survival Analysis; Trifluoperazine; Yersinia pestis	2016
New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection. mBio, 2020, 03-10, Volume: 11, Issue:2 Topics: Amoxapine; Animals; Clostridioides difficile; Clostridium Infections; Doxapram; Drug Repositioning; Female; Immunity, Innate; Immunomodulation; Male; Mice; Mice, Inbred C57BL; Microbiota; RNA-Seq; Specific Pathogen-Free Organisms; Trifluoperazine	2020

Article

Year

New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.

Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

Topics: Amoxapine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Clostridioides difficile; Disease Models, Animal; Doxapram; Drug Administration Schedule; Drug Repositioning; Enterocolitis, Pseudomembranous; Female; High-Throughput Screening Assays; Macrophages; Mice; Plague; Prescription Drugs; Salmonella Infections; Salmonella typhimurium; Small Molecule Libraries; Survival Analysis; Trifluoperazine; Yersinia pestis

2016

New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.

mBio, 2020, 03-10, Volume: 11, Issue:2

Topics: Amoxapine; Animals; Clostridioides difficile; Clostridium Infections; Doxapram; Drug Repositioning; Female; Immunity, Innate; Immunomodulation; Male; Mice; Mice, Inbred C57BL; Microbiota; RNA-Seq; Specific Pathogen-Free Organisms; Trifluoperazine

2020